Publications
5541 Results
- Journal / Conference
- Cancer Chemotherapy Reports 40:47-48
- Year
- 1964
- Research Committee(s)
- Genitourinary and Gynecologic
Phase II studies of hydroxyurea (NSC-32065) in adults: Urologic and gynecologic neoplasms.
- Journal / Conference
- Cancer Chemotherapy Reports 40:57-74
- Year
- 1964
- Research Committee(s)
- Leukemia
Antileukemic activity of hydroxyurea (NSC-32065) and other urea derivatives
- Journal / Conference
- Cancer Chemotherapy Reports 40:49-50
- Year
- 1964
- Research Committee(s)
- Leukemia
Phase II studies of hydroxyurea (NSC-32065) in adults: Leukemia
- Journal / Conference
- Cancer Chemotherapy Reports 40:45-46
- Year
- 1964
- Research Committee(s)
- Lung
Phase II studies of hydroxyurea (NSC-32065) in adults: Carcinoma of the lung.
- Journal / Conference
- Cancer Chemotherapy Reports 40:51-52
- Year
- 1964
- Research Committee(s)
- Lymphoma and Myeloma
Phase II studies of hydroxyurea (NSC-32065) in adults: Multiple myeloma and lymphoma.
- Journal / Conference
- Cancer Chemotherapy Reports 40:27-30
- Year
- 1964
Erythrokinetic abnormalities with administration of hydroxyurea (NSC-32065).
- Journal / Conference
- Cancer Chemotherapy Reports 40:15-17
- Year
- 1964
Megaloblastic erythropoiesis induced by hydroxyurea.
- Journal / Conference
- Cancer Chemotherapy Reports 40:37-38
- Year
- 1964
Pediatric clinical trials with hydroxyurea (NSC-30265).
- Journal / Conference
- Cancer Chemotherapy Reports 40:19-22
- Year
- 1964
Studies on a metabolic defect induced by hydroxyurea (NSC-30265).
- Journal / Conference
- Cancer Chemotherapy Reports 40:33-36
- Year
- 1964